Kairos Pharma extends equity line with Helena, presents ENV-105 data at Houston conferenceNov 3PartnershipKairos Pharma, LTD.
Kairos Pharma reports positive interim PFS data for ENV-105 in prostate cancer trialOct 6Clinical readoutKairos Pharma, LTD.
Kairos Pharma signs research agreement with Bayer to test ENV-105 with XOFIGO in prostate cancerJul 22Clinical readoutKairos Pharma, LTD.radium ra 223 dichloride